Takeda Pharmaceutical Co. Ltd. - Other Non Cash Items

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Other-Non-Cash-Items" stands at 154.25 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025.

Takeda Pharmaceutical Co. Ltd.'s second quarter result of 90.37 Billion JPY for the item "Other Non Cash Items" represents an increase of 400.03 percent compared to it's first quarter result.

Also, Takeda Pharmaceutical Co. Ltd.'s second quarter result of 90.37 Billion JPY for the item "Other Non Cash Items" represents an increase of 64.45 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Takeda Pharmaceutical Co. Ltd.'s second quarter result of 154.25 Billion JPY for the item "Other Non Cash Items" represents an increase of 29.80 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 80.62 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 80.62 Billion Japanese Yens.
The 3 year change is 142.80 Billion Japanese Yens.
The 5 year change is 228.11 Billion Japanese Yens.
The 10 year change is 254.20 Billion Japanese Yens.

The Serie's long term average value is -38.89 Billion Japanese Yens. It's latest available value, on 09/30/2025, is 193.14 Billion Japanese Yens higher, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 03/31/2021, to it's latest available value, on 09/30/2025, is +498.42 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 03/31/2025, to it's latest available value, on 09/30/2025, is -8.40 Billion.